American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6400)
  2. Solid Tumor Oncology Division (5538)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1379)
  9. Gastrointestinal Oncology Service (1354)
  10. Hematologic Malignancies, Division of (1281)
Search Within
Formats
  1. Meeting Abstract (6334)
  2. Journal Article (2582)
  3. Editorial (76)
  4. Review (68)
  5. Guidelines (55)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6400)
  2. Solid Tumor Oncology Division (5538)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (306)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (279)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8697)
  2. JCO Precision Oncology (171)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (8)

More Publications

Results (9171)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of bridging therapy (BT) on lisocabtagene maraleucel (liso-cel) treatment in patients (pt) with R/R follicular lymphoma (FL)
    Meeting Abstract

    Reguera, J. L.; Garcia-Sancho, A. M.; Kuruvilla, J.; Izutsu, K.; Barbui, A. M.; Peter, B.; Mielke, S.; Palomba, M. L.; Cartron, G.; Ghesquieres, H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Health-related quality of life and pain in a phase 3 study of [(177)Lu] Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)
    Meeting Abstract

    Fizazi, K.; Morris, M. J.; Shore, N. D.; Chi, K. N.; Crosby, M.; De Bono, J. S.; Herrmann, K.; Roubaud, G.; Nagarajah, J.; Fleming, M. T.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy, safety, and patient-reported outcomes of vimseltinib in patients with tenosynovial giant cell tumor: Results from the phase 3 MOTION trial
    Meeting Abstract

    Tap, W. D.; Bhadri, V.; Stacchiotti, S.; Bauer, S.; Wagner, A. J.; de Sande, M. V.; Bernthal, N. M.; Pousa, A. L.; Razak, A. R. A.; Italiano, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • HB-200 arenavirus-based immunotherapy plus pembrolizumab as first-line treatment of patients with recurrent/metastatic HPV16-positive head and neck cancer: Updated results
    Meeting Abstract

    Ho, A. L.; Nabell, L.; Neupane, P. C.; Posner, M. R.; Yilmaz, E.; Niu, J.; Naqash, A. R.; Pearson, A. T.; Wong, S. J.; Nieva, J. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Results from the bladder cohort of the DESTINY-PanTumor02 (DP-02) study
    Meeting Abstract

    Wysocki, P. J.; Jung, K. H.; Oh, D. Y.; Doroshow, D. B.; Artamonova, E.; Mammatas, L.; Su, P. J.; Moiseyenko, V.; Penkov, K.; Stroyakovskiy, D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Pooled analysis by best confirmed response to trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ metastatic breast cancer (mBC) from DESTINY-Breast-01,-02, and-03
    Meeting Abstract

    Saura, C.; CorteĢs, J.; Modi, S.; Kim, S. B.; Hamilton, E. P.; Hurvitz, S. A.; Krop, I. E.; Curigliano, G.; Iwata, H.; Im, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial
    Meeting Abstract

    D'Angelo, S. P.; Furness, A. J. S.; Thistlethwaite, F.; Burgess, M. A.; Riedel, R. F.; Haanen, J.; Noujaim, J.; Chalmers, A. W.; Pousa, Alpo; Chugh, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • GEMINI-Hepatobiliary: A phase 2 study of novel first-line immuno-oncology-based treatments in patients with advanced hepatobiliary cancers
    Meeting Abstract

    Zhou, J.; Cheng, A. L.; Ikeda, M.; Lim, H. Y.; Akce, M.; Qin, S.; Oh, D. Y.; Chan, S. L.; Xiang, J.; Qu, X.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Comparison of clinical outcomes of stable disease with confirmed tumor reduction and RECIST partial response for tebentafusp in metastatic uveal melanoma (mUM)
    Meeting Abstract

    Ikeguchi, A.; Sato, T.; Butler, M. O.; Carvajal, R. D.; Sacco, J. J.; Shoushtari, A. N.; Hassel, J. C.; Nathan, P. D.; Piulats, J. M.; Johnson, D. B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Final overall survival results from phase 3 SPOTLIGHT study evaluating zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, HER2-, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
    Meeting Abstract

    Shitara, K.; Van Cutsem, E.; Lordick, F.; Enzinger, P. C.; Ilson, D. H.; Shah, M. A.; Xu, R. H.; Lonardi, S.; Yamaguchi, K.; Hung, Y. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save